Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report By Product Type, By Form (Aqueous, Non-Aqueous Liquid, Dry Powder), By Manufacturer Type, By Application, By Region

Description

List of Tables

The active pharmaceutical ingredient market size is expected to reach USD 468.0 billion by 2034, according to a new study by Polaris Market Research. The report "Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form (Aqueous, Non-Aqueous Liquid, and Dry Powder), Manufacturer Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The active pharmaceutical ingredient (API) market growth is driven by increasing demand for generic drugs and over-the-counter drugs worldwide. For instance, the retail sales of over-the-counter drugs in the US have risen to 43.4 billion USD in 2023 from 14.7 billion dollar USD in 2000. This represents a significant increase of 33 billion dollar USD from 2000 to 2023. Additionally, the sales revenue of OTC drugs from 2018 to 2023 has grown by 3.6%

Increasing investments and funding from public and private capitalists are anticipated to fuel active pharmaceutical market growth. Advancements in drug formulations, production, and short drug discovery timelines have been attracting investors seeking better returns on their investments. For instance, in August 2024, Vivint Pharma, a leading injectables pharmaceutical company, announced plans to build an advanced injectables manufacturing facility in Genome Valley, Hyderabad. The company will invest $48 million in the new facility, which is expected to create 1,000 jobs and strengthen Telangana's position as a global life sciences hub. The announcement was made during a high-level meeting with Telangana's Chief Minister, Shri A. Revanth Reddy, and Minister for Industries and Commerce, Sri D. Sridhar Babu, in the US. Vivint Pharma, which already has a $8.5 million R&D center in Genome Valley, is expanding its footprint in India. The company has acquired 5.5 acres in Genome Valley, known for its world-class infrastructure and innovation ecosystem, to support its entry into international markets.

Pharmaceutical companies are major consumers and manufacturers of active pharmaceutical ingredients. Increasing investment and government incentives have led to a rise in the number of new players with innovative ideas, challenging the existing pharmaceutical giants.

Active Pharmaceutical Ingredient (API) Market Report Highlights

By form analysis, the aqueous segment is anticipated to experience substantial growth with a significant CAGR in the market. This growth is attributed to the wide range of applications of the aqueous active pharmaceutical ingredient in different forms of drugs.

In 2024, North America dominated the API market due to the established presence of several companies within the region.

The active pharmaceutical ingredient (API) market in China is projected for substantial growth due to the regulatory support and funding for biotech innovations within the country.

The key market players are Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the active pharmaceutical ingredient market report based on product type, form, manufacturer type, application, and region:

By Product Type Outlook (Revenue - USD Billion, 2021-2034)

mAb

Immunoglobulin

Cytokines

Insulin

Peptide Hormones

Blood Factors

Peptide Antibiotics

Vaccines

Small Molecule Antibiotics

Highly Potent Active Pharmaceutical Ingredient (HPAPI)

Others

By Form Outlook (Revenue - USD Billion, 2021-2034)

Aqueous

Non-Aqueous Liquid

Dry Powder

By Manufacturer Type Outlook (Revenue - USD Billion, 2021-2034)

Captive

Merchant

By Application Outlook (Revenue - USD Billion, 2021-2034)

Cardiology

Oncology

CNS & Neurology

Orthopedic

Endocrinology

Pulmonology

Gastroenterology

Nephrology

Ophthalmology

Others

By Regional Outlook (Revenue - USD Billion, 2021-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of the Middle East & Africa

Product Code: PM1703

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Active Pharmaceutical Ingredient (API) Market Insights

4.1. Active Pharmaceutical Ingredient (API) Market - Market Snapshot
4.2. Active Pharmaceutical Ingredient (API) Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Investment in Pharmaceutical Sector is Driving the Market Size
  - 4.2.1.2. Increasing Number of Pipeline Drugs Are Driving the Market Growth
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Skilled Workforce
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Active Pharmaceutical Ingredient (API) Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Active Pharmaceutical Ingredient (API) Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
5.3. mAb
- 5.3.1. Global Active Pharmaceutical Ingredient (API) Market, by mAb, by Region, 2021-2034 (USD Billion)
5.4. Immunoglobulin
- 5.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Immunoglobulin, by Region, 2021-2034 (USD Billion)
5.5. Cytokines
- 5.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Cytokines, by Region, 2021-2034 (USD Billion)
5.6. Insulin
- 5.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Insulin, by Region, 2021-2034 (USD Billion)
5.7. Peptide Hormones
- 5.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Hormones, by Region, 2021-2034 (USD Billion)
5.8. Blood Factors
- 5.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Blood Factors, by Region, 2021-2034 (USD Billion)
5.9. Peptide Antibiotics
- 5.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Antibiotics, by Region, 2021-2034 (USD Billion)
5.10. Vaccines
- 5.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Vaccines, by Region, 2021-2034 (USD Billion)
5.11. Small Molecule Antibiotics
- 5.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Small Molecule Antibiotics, by Region, 2021-2034 (USD Billion)
5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
- 5.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2021-2034 (USD Billion)
5.13. Others
- 5.13.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2021-2034 (USD Billion)

6. Global Active Pharmaceutical Ingredient (API) Market, by Form

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
6.3. Aqueous
- 6.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Aqueous, by Region, 2021-2034 (USD Billion)
6.4. Non-Aqueous Liquid
- 6.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Non-Aqueous Liquid, by Region, 2021-2034 (USD Billion)
6.5. Dry Powder
- 6.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Dry Powder, by Region, 2021-2034 (USD Billion)

7. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
7.3. Captive
- 7.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Captive, by Region, 2021-2034 (USD Billion)
7.4. Merchant
- 7.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Merchant, by Region, 2021-2034 (USD Billion)

8. Global Active Pharmaceutical Ingredient (API) Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
8.3. Cardiology
- 8.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Cardiology, by Region, 2021-2034 (USD Billion)
8.4. Oncology
- 8.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Oncology, by Region, 2021-2034 (USD Billion)
8.5. CNS & Neurology
- 8.5.1. Global Active Pharmaceutical Ingredient (API) Market, by CNS & Neurology, by Region, 2021-2034 (USD Billion)
8.6. Orthopedic
- 8.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Orthopedic, by Region, 2021-2034 (USD Billion)
8.7. Endocrinology
- 8.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Endocrinology, by Region, 2021-2034 (USD Billion)
8.8. Pulmonology
- 8.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Pulmonology, by Region, 2021-2034 (USD Billion)
8.9. Gastroenterology
- 8.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Gastroenterology, by Region, 2021-2034 (USD Billion)
8.10. Nephrology
- 8.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2021-2034 (USD Billion)
8.11. Ophthalmology
- 8.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2021-2034 (USD Billion)
8.12. Others
- 8.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2021-2034 (USD Billion)

9. Global Active Pharmaceutical Ingredient (API) Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Active Pharmaceutical Ingredient (API) Market Assessment, By Geography, 2021-2034 (USD Billion)
9.3. Active Pharmaceutical Ingredient (API) Market - North America
- 9.3.1. North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
- 9.3.2. North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
- 9.3.3. North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
- 9.3.4. North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.3.5. Active Pharmaceutical Ingredient (API) Market - U.S.
  - 9.3.5.1. U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.3.5.2. U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.3.5.3. U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.3.5.4. U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.3.6. Active Pharmaceutical Ingredient (API) Market - Canada
  - 9.3.6.1. Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.3.6.2. Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.3.6.3. Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.3.6.4. Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
9.4. Active Pharmaceutical Ingredient (API) Market - Europe
- 9.4.1. Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
- 9.4.2. Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
- 9.4.3. Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
- 9.4.4. Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.5. Active Pharmaceutical Ingredient (API) Market - UK
  - 9.4.5.1. UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.5.2. UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.5.3. UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.5.4. UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.6. Active Pharmaceutical Ingredient (API) Market - France
  - 9.4.6.1. France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.6.2. France: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.6.3. France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.6.4. France: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.7. Active Pharmaceutical Ingredient (API) Market - Germany
  - 9.4.7.1. Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.7.2. Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.7.3. Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.7.4. Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.8. Active Pharmaceutical Ingredient (API) Market - Italy
  - 9.4.8.1. Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.8.2. Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.8.3. Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.8.4. Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.9. Active Pharmaceutical Ingredient (API) Market - Spain
  - 9.4.9.1. Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.9.2. Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.9.3. Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.9.4. Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.10. Active Pharmaceutical Ingredient (API) Market - Netherlands
  - 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.11. Active Pharmaceutical Ingredient (API) Market - Russia
  - 9.4.11.1. Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.11.2. Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.11.3. Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.11.4. Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.4.12. Active Pharmaceutical Ingredient (API) Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
9.5. Active Pharmaceutical Ingredient (API) Market - Asia Pacific
- 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
- 9.5.2. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
- 9.5.3. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
- 9.5.4. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.5. Active Pharmaceutical Ingredient (API) Market - China
  - 9.5.5.1. China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.5.2. China: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.5.3. China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.5.4. China: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.6. Active Pharmaceutical Ingredient (API) Market - India
  - 9.5.6.1. India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.6.2. India: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.6.3. India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.6.4. India: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.7. Active Pharmaceutical Ingredient (API) Market - Malaysia
  - 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.8. Active Pharmaceutical Ingredient (API) Market - Japan
  - 9.5.8.1. Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.8.2. Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.8.3. Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.8.4. Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.9. Active Pharmaceutical Ingredient (API) Market - Indonesia
  - 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.10. Active Pharmaceutical Ingredient (API) Market - South Korea
  - 9.5.10.1. South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.10.2. South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.10.3. South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.10.4. South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.11. Active Pharmaceutical Ingredient (API) Market - Australia
  - 9.5.11.1. Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.11.2. Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.11.3. Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.11.4. Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.5.12. Active Pharmaceutical Ingredient (API) Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
9.6. Active Pharmaceutical Ingredient (API) Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.6.5. Active Pharmaceutical Ingredient (API) Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.6.6. Active Pharmaceutical Ingredient (API) Market - UAE
  - 9.6.6.1. UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.6.6.2. UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.6.6.3. UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.6.6.4. UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.6.7. Active Pharmaceutical Ingredient (API) Market - Israel
  - 9.6.7.1. Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.6.7.2. Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.6.7.3. Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.6.7.4. Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.6.8. Active Pharmaceutical Ingredient (API) Market - South Africa
  - 9.6.8.1. South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.6.8.2. South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.6.8.3. South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.6.8.4. South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.6.9. Active Pharmaceutical Ingredient (API) Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
9.7. Active Pharmaceutical Ingredient (API) Market - Latin America
- 9.7.1. Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
- 9.7.2. Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
- 9.7.3. Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
- 9.7.4. Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.7.5. Active Pharmaceutical Ingredient (API) Market - Mexico
  - 9.7.5.1. Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.7.5.2. Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.7.5.3. Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.7.5.4. Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.7.6. Active Pharmaceutical Ingredient (API) Market - Brazil
  - 9.7.6.1. Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.7.6.2. Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.7.6.3. Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.7.6.4. Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.7.7. Active Pharmaceutical Ingredient (API) Market - Argentina
  - 9.7.7.1. Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.7.7.2. Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.7.7.3. Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.7.7.4. Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
- 9.7.8. Active Pharmaceutical Ingredient (API) Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Pfizer
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Teva Pharmaceuticals Ltd
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. GSK PLC
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Sanofi
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Eli Lilly and Company
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Merck KGaA
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. AbbVie Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. F-Hoffman La Roche Ltd
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. AstraZeneca
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Dr. Reddy's Laboratory
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. BASF Corporation
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Sun Pharmaceuticals Industries Ltd.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Curia Global Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development